Investigators from University of North Carolina Chapel Hill Zero in on Pancreatic Cancer (Concurrent Inhibition of the Ras-mapk Pathway and Pikfyve Is a Therapeutic Strategy for Pancreatic Cancer)

Press/Media

Period2 Jun 2025

Media coverage

1

Media coverage

  • TitleInvestigators from University of North Carolina Chapel Hill Zero in on Pancreatic Cancer (Concurrent Inhibition of the Ras-mapk Pathway and Pikfyve Is a Therapeutic Strategy for Pancreatic Cancer)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date2/06/25
    PersonsEmmanuel Petricoin
View all 1
View less

Related content